Skip to content
by Legal Desire
21 September 2026

Latham & Watkins Advises on Electra Therapeutics’ Upsized US$350 Million Initial Public Offering

Advising firms

Deal team

14 lawyers named
LawyerFirmSeniorityPracticeOffice
Matt Bush Lead Latham & Watkins LLP Partner Capital Markets San Diego
Omeed Valipour Latham & Watkins LLP Associate Capital Markets Not stated
Ariana Alemi Latham & Watkins LLP Associate Capital Markets Not stated
Chad Jennings Latham & Watkins LLP Counsel FDA matters Washington, D.C.
Trevor Thompson Latham & Watkins LLP Associate FDA matters Not stated
Betty Pang Latham & Watkins LLP Partner healthcare matters Bay Area
Heather Deixler Latham & Watkins LLP Partner data privacy and cybersecurity matters Bay Area
Chad Leiper Latham & Watkins LLP Associate data privacy and cybersecurity matters Not stated
Robert Yeh Latham & Watkins LLP Counsel intellectual property matters San Diego
Andrew Wang Latham & Watkins LLP Associate intellectual property matters Not stated
Holly Bauer Latham & Watkins LLP Partner executive compensation and employee benefits matters San Diego
Julie Voorhes Latham & Watkins LLP Associate executive compensation and employee benefits matters Not stated
Eric Cho Latham & Watkins LLP Partner tax matters Los Angeles
Sina Setayeshpour Latham & Watkins LLP Associate tax matters Not stated

11 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 350m (US$350 million)
What the figure measures
Issue size
Client
Electra Therapeutics, Inc.Issuer
Counterparties
the underwriters (Underwriters)